支持还是简化:两期胸肌前乳房再造中补片使用的评估
多中心回顾性队列纳入2016至2025年即时胸肌前两期乳房再造,按扩张器置入时是否使用补片分层;共948例患者1592侧再造,84.4%使用补片。使用补片者并发症更多(18.2% vs. 12.9%,p=0.039),主要为感染(8.7% vs. 4.8%,p=0.039);多变量分析示补片与并发症风险升高相关(OR:1.574,95%CI:1.047-2.437,p=0.035),但与再造失败及二次修整无显著关联。
要点
- 补片使用与术后并发症风险升高相关,主要为感染。
- 补片未降低再造失败率或二次修整率。
- 两期胸肌前再造中常规使用补片可能并无必要。
核心结论
- 在胸肌前两期乳房再造中,使用补片与术后并发症增加相关,尤其是感染,且未降低再造失败或二次修整率。
- 补片是乳房再造常用的辅助工具,但在两期再造中常规使用成本较高且可能并无必要。
研究设计与样本
- 多中心回顾性队列研究,纳入2016至2025年接受即时胸肌前两期乳房再造的患者,按扩张器置入时是否使用补片分层。
- 排除延期再造或同期/计划自体重建者;最终样本为948例患者的1592侧再造,其中84.4%使用补片。
主要发现
- 使用补片的再造侧并发症发生率更高(18.2% vs. 12.9%,p=0.039),主要因感染率更高(8.7% vs. 4.8%,p=0.039)。
- 多变量分析中,补片使用与并发症风险升高相关(OR:1.574,95%CI:1.047-2.437,p=0.035)。
- 补片使用与再造失败无显著关联(OR:1.222,95%CI:0.684-2.181,p=0.499)。
- 两组二次修整率无显著差异(21.5% vs. 24.4%,p=0.333),补片未显示对二次修整有保护作用(OR:1.165,95%CI:0.821-1.653,p=0.392)。
临床怎么用
- 两期胸肌前乳房再造决策时可权衡补片的感染风险与成本,不将其作为常规必需步骤。
- 对拟使用补片者应加强感染监测与防控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The routine use of surgical mesh in prepectoral two-stage breast reconstruction has increased despite limited high-level evidence supporting its necessity. The purpose of this study was to evaluate whether mesh use impacts postoperative complications, reconstructive failure, or secondary revision rates. METHODS: A multicenter retrospective cohort study was conducted of patients undergoing immediate prepectoral two-stage breast reconstruction from 2016 to 2025, stratified by use of mesh at the time of expander placement. Patients undergoing delayed reconstruction or concurrent/planned autologous reconstruction were excluded. Logistic regression models assessed predictors of (1) postoperative complication, (2) reconstructive failure, and (2) secondary revision. RESULTS: The final sample included 1,592 reconstructions in 948 patients, of which 84.4% used mesh. Complications occurred more frequently in reconstructions with mesh (18.2% vs. 12.9%, p=0.039), primarily due to higher infection rates (8.7% vs. 4.8%, p=0.039). On multivariable analysis, mesh use was associated with increased odds of complication (OR: 1.574, 95% CI: 1.047-2.437, p=0.035) but not reconstructive failure (OR: 1.222, 95% CI: 0.684-2.181, p=0.499). Secondary revision rates did not differ significantly between the two cohorts (21.5% vs. 24.4%, p=0.333) and mesh use was not found to be protective of secondary revision (OR: 1.165, 95% CI: 0.821-1.653, p=0.392). CONCLUSION: In prepectoral two-stage breast reconstruction, mesh use was associated with increased postoperative complications, particularly infection, and did not confer a reduction in reconstructive failure or secondary revision rates. While mesh is a useful adjunctive tool commonly used in breast reconstruction, its routine incorporation in two-stage reconstruction is costly and may not be necessary.
引用
- DePamphilis MA, Lee J, McGlynn MN, et al. Support or Simplicity: Evaluating Mesh Use in Two-Stage Prepectoral Breast Reconstruction. Plast Reconstr Surg. 2026. PMID: 42872925. doi:10.1097/PRS.0000000000013500
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。